Dietary components and human platelet activity

Platelets

Volumn 13, Issue 2, 2002, Pages 67-75

  Dutta Roy, Asim K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; ANTITHROMBOCYTIC AGENT;

CARDIOVASCULAR DISEASE; DIET; FIBRINOLYTIC THERAPY; FRUIT; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION; VEGETABLE; CHEMISTRY; DRUG EFFECT; MEDICINAL PLANT; THROMBOCYTE ACTIVATION;

CARDIOVASCULAR DISEASES; DIET; FRUIT; HUMANS; PLANTS, MEDICINAL; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; VEGETABLES;

EID: 0036107689     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100120111540     Document Type: Review

References (91)

1. Platelets and vascular smooth muscle: Abnormalities of phosphodiesterase, aggregation, and cell growth in experimental and human diabetes
2. Biochemical mechanism of platelet activation
3. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: Effect of essential fatty acid metabolism
4. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets
5. Biochemical mechanism of platelet activation
6. New antiplatelet agents: Platelet GPIIb/GPIIIa antagonists
7. Pharmacology of platelet inhibitors
8. 1/prostacyclin receptor of human blood platelets
9. Cytochrome P4502C is an EDHF synthase in coronary arteries
10. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets
11. A new group of biologically active compounds derived from prostaglandin endoperoxides
12. Acute coronary syndromes: Pathophysiology and preventive priorities
13. Coronary plaque disruption
14. The pathogenesis of coronary artery disease and the acute coronary syndromes, part-1
15. The pathogenesis of coronary artery disease and the acute coronary syndromes, part-2
16. Overview of results of randomized clinical trials in heart disease, unstable angina, heart failure, primary prevention with aspirin, and risk factor modification
17. Anti-platelet drugs - A comparative review
18. Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis
19. Fatty acid transport and metabolism in the feto-placental unit and the role of fatty acid-binding proteins
20. The biosynthesis and metabolism of prostaglandins
21. Mechanisms of action of anti-inflammatory drugs
22. Arachidonic acid uptake by human platelets is mediated by CD36
23. Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: Effect on arachidonic acid uptake
24. Biochemical and nutritional aspects of eicosanoids
25. 1: The endogenous physiological regulator of platelet mediated blood co-agulation
26. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis
27. The inverse relationship between fish consumption and 20 years mortality from coronary heart disease
28. Dose response relationships for w3/w6 effects
29. Arachidonic acid metabolism
30. n-3 polyunsaturated fatty acids in ischaemic heart disease
31. Vitamin E requirements, transport, and metabolism: Role of α-tocopherol-binding proteins
32. Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men
33. Effects of n-3 and n-6 fatty acid supplementation on cardiovascular and endocrine responses to stress in the rat
34. Inhibition of platelet function by cis-unsaturated fatty acids
35. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables
36. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men
37. Inhibition of venom phospholipase A2 by manoalide and manoalogue: Stoichiometry of incorporation
38. Some pharmacological observations on marine natural products
39. Two-step inactivation of bee venom phospholipase A2 by scalaradial
40. Allixin, a stress compound from garlic
41. Cancer preventive agents in processed garlic
42. 2 activity and superoxide generation in macrophages
43. 2 and platelet aggregation by glycyrrhizin, an anti-inflammatory drug
44. Two new inhibitors of phospholipase A2 produced by Penicillum chermesinum
45. 2
46. Pilpstatins: New inhibitors of phospholipase A2, produced by Bacillus cereus BM G302-fF67III. Structural elucidation of pilpstatins
47. An approach to the genus Tanacetum L. (Compositae): Phytochemical and pharmacological review
48. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
49. Onion exerts anti-aggregatory effects by altering arachidonic acid metabolism in platelets
50. Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic metabolism in human blood platelets
51. Organosulfur chemistry of garlic and onion: Recent results
52. Biologically active thiosulphinates and sulphinyl-disulphides from Allium cepa
53. Antithrombotic organosulphur compounds from garlic: Structural, mechanistic and synthetic studies
54. Sulphur chemistry of onions and inhibitory factors of the arachidonic acid cascade
55. Antiplatelet effect of gingerol isolated from Zingiber officinale
56. Effects of chalcones isolated from licorice root on leukotriene biosynthesis in human polymorphonuclear neutrophils
57. Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract
58. Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related compounds
59. Structure of antioxidative compounds in ginger
60. Chemistry of ginger components and inhibitory factors of the arachidonic acid cascade
61. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids
62. Red wine polyphenols and inhibition of platelet aggregation: Possible mechanism, and potential use in health promotion and disease prevention
63. A global survey of trans-resveatrol concentrations in commercial wines
64. Effects of stilbenes on arachidonate metabolism in leukocytes
65. Antioxidant action of resveratrol in lipid-peroxidation
66. More on antioxidant activity of resveratrol in red wine
67. Antiplatelet activity of synthetic and natural resveratrol in red wine
68. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release
69. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
70. Inhibition of 12-O-tetradecanoylphorbol-13-acetate caused tumor promotion in 7,12-dimethylbenz-anthren-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea
71. Role of nutmeg in inhibiting prostaglandin biosynthesis
72. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbal-13-acetate
73. Inhibitory effect of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis
74. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets
75. Novel platelet antiaggregating substances
76. Gingko biloba
77. Inhibitory effect of Ginkgo biloba on human platelet aggregation
78. Modification of platelet function and arachidonic acid metabolism by bioflavonoids
79. Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources
80. α-tocopherol binding proteins: Purification and characterization
81. The effects of some flavone drugs on the conversion of prostacyclin to 6-keto prostaglandin E1
82. Inhibition of in vitro platelet aggregation and arachidonic acid metabolism by flavone
83. Effects of tomato extract on human platelet aggregation in vitro
84. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: A review with particular emphasis on implications for cardiovascular disease
85. A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting blood lipids, and haemostatic variables in young healthy men
86. The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans
87. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans
88. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
89. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation
90. Old and new natural products as the source of modern anti-thrombotic drugs